Mary Ann Liebert, Inc., publishers

Simulation is a valuable tool to improve the energy efficiency of machines and it is now being used to analyze and optimize soft robotic systems to increase their utility, as described in an article published in Soft Robotics, a peer-reviewed journal...

Stephen K. Klasko, MD, MBA has put forth a manifesto (http://www.liebertpub.com/…/heat-healthcare-under-trump/195/) that will enable the incoming Trump administration to hit the ground running immediately with regard to healthcare reform. Dr.

Commercializing a new, innovative product is often the greatest challenge across the research and development landscape, as is evident in the failed attempt to bring jamming-based robotic gripper technology to market.

In the past 3 years, both LGBT Health (http://www.liebertpub.com/lgbt) and the field of LGBT health have made advances that can be attributed, in large measure, to progressive changes and support under the Obama administration.

A new study shows that a rat model of metabolic syndrome fed a high-sugar and high-cholesterol diet and given blue maize extract showed significant improvement in systolic blood pressure, high density lipoprotein (HDL) cholesterol, and triglyceride...

New evidence-based recommendations from the American Thyroid Association (ATA) provide guidance to clinicians in diagnosing and managing thyroid disease during pregnancy and the postpartum period.

To understand the molecular mechanisms involved in the interaction of bone with orthopedic implants comprised of novel biomaterials, researchers have made a mouse model in which they can assess early tissue responses to surfaces such as bioactive glass.

Liver-directed gene therapy delivered using adeno-associated viral (AAV) vectors to treat diseases such as hemophilia have advanced into human testing.

The lacrimal gland of the eye secretes a major component of tears, yet surprisingly little is still understood about the signaling pathways that activate lacrimal gland secretions.

Many gene therapy-based approaches are in development to combat genetic and other causes of blindness and vision loss, and much can be learned about the safety and effectiveness of these promising new therapies by studying them first in non-human...